Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ofira Ben-Tal"'
Publikováno v:
The Israel Medical Association journal : IMAJ. 17(10)
Approximately 80% of patients with myelodysplastic syndromes (MDS) receive multiple red blood cells (RBC), often multiple transfusions, and are therefore prone to develop alloantibodies against RBC. Because of increasing evidence for the role of immu
Autor:
Y. Levy, Sven Danckwardt, B. Katz, V. Deutsch, Andreas E. Kulozik, R. Eichele, Matthias W. Hentze, Ofira Ben-Tal, K. Hartmann
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:1078-1085
Summary. Background: Mutations of the 3′ end mRNA-processing signal of the prothrombin (F2) gene have been reported to cause elevated F2 plasma concentrations, thrombosis, and complications of pregnancy. Whereas the common F2 20210*A mutation is al
Publikováno v:
Leukemia & Lymphoma. 45:1407-1411
Treatment with intensive chemotherapy regimens is frequently complicated by severe thrombocytopenia. During the period of severe thrombocytopenia, anticoagulant treatment is not uncommonly indicated for thromboembolic events or thromboprophylaxis in
Publikováno v:
Transfusion. 43:873-877
BACKGROUND: FFP is considered adequate for transfusion up to 24 hours after thawing and is currently used most often to replace deficient clotting factors, such as in warfarin overdose. We set to examine the levels of vitamin K-dependent factors (i.e
Autor:
Ella Naparstek, Chaim Brautbar, Shimon Slavin, Avraham Amar, Memet Aker, Amiram Eldor, Mark Kirschbaum, Aliza Ackerstein, Yossi Kapelushnik, Ofira Ben-Tal, G. Varadi, Reuven Or, Simcha Samuel, Arnon Nagler, Gabriel Cividalli
Publikováno v:
Blood. 91:756-763
Myeloablative conditioning associated with hazardous immediate and late complications is considered as a mandatory first step in preparation for allogeneic blood or marrow transplantation (allogeneic BMT) for the treatment of malignant hematologic di
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 28:256-259
High-dose intravenous immune globulin (IV IgG) is currently the treatment of choice for patients with idiopathic thrombocytopenic purpura (ITP) who undergo splenectomy; however, this treatment is extremely expensive. We report on 13 ITP patients with
Publikováno v:
Journal of perinatal medicine. 41(5)
Objective: To establish the frequency of post-cesarean relaparotomy, identify its risk factors, indications, and operative management. Methods: This study was a retrospective matched case control study. Records of all women who underwent a cesarean s
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 15:S231
Context: Approximately 80% of patients with MDS receive multiple red blood cell (RBS) transfusions and are therefore prone to develop RBC alloantibodies. Recent data suggest that immune deregulation plays a major role in the pathogenesis of MDS. Beca
Publikováno v:
Transfusion. 43(7)
FFP is considered adequate for transfusion up to 24 hours after thawing and is currently used most often to replace deficient clotting factors, such as in warfarin overdose. We set to examine the levels of vitamin K-dependent factors (i.e., prothromb
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:2288-2289